JEG-3Homo sapiens (Human)Cancer cell line

Also known as: jeg3, Jeg3, JEG3, Jeg-3

🤖 AI SummaryBased on 16 publications

Quick Overview

Human choriocarcinoma cell line used in cancer research.

Detailed Summary

JEG-3 is a human choriocarcinoma cell line derived from a malignant trophoblast tumor. It is widely used in research for studying placental function, hormone production, and cancer biology. JEG-3 cells are known for their ability to secrete active retinoids and chorionic gonadotropin (HCG), making them valuable for investigating placental hormone regulation and tumor development. The cell line has been utilized in studies related to genetic diversity, tumor metastasis, and the role of specific genes in cancer progression. Research on JEG-3 has contributed to understanding the molecular mechanisms of choriocarcinoma and its implications in pregnancy-related cancers.

Research Applications

Cancer researchPlacental function studiesHormone production analysisGenetic diversity studiesTumor metastasis investigation

Key Characteristics

Secretes active retinoidsProduces chorionic gonadotropin (HCG)Used in studies of placental hormone regulationRelevant for understanding choriocarcinoma biology
Generated on 6/15/2025

Basic Information

Database IDCVCL_0363
SpeciesHomo sapiens (Human)
Tissue SourceFetal brain[UBERON:UBERON_0006238]

Donor Information

Age CategoryFetus
SexMale

Disease Information

DiseaseGestational choriocarcinoma
LineageUterus
SubtypeChoriocarcinoma
OncoTree CodeUCCA

DepMap Information

Source TypeATCC
Source IDACH-001530_source

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
11,12
D10S1248
13,15
D12S391
17,24
D13S317
9,11
D16S539
13,14
D18S51
14
D19S433
13,15
D1S1656
14,16
D21S11
30
D22S1045
15
D2S1338
24
D2S441
14,15
D3S1358
15
D5S818
10,11
D7S820
10,12
D8S1179
12
FGA
23,24
Penta D
9,12
Penta E
8,12
SE33
15,25.2
TH01
9,9.3
TPOX
8
vWA
16
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Molecular characteristics of established trophoblast-derived cell lines.

Morales-Prieto D.M.

Placenta 108:122-133(2021).

Cytogenomics of six human trophoblastic cell lines.";

Liehr T., Markert U.R.

Placenta 103:72-75(2021).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A comparative study of five physiological key parameters between four different human trophoblast-derived cell lines.

Rothbauer M., Patel N., Gondola H., Siwetz M., Huppertz B., Ertl P.

Sci. Rep. 7:5892-5892(2017).

HTR-8/SVneo cell line contains a mixed population of cells.";

Abou-Kheir W., Barrak J., Hadadeh O., Daoud G.

Placenta 50:1-7(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Microarray analysis of BeWo and JEG3 trophoblast cell lines: identification of differentially expressed transcripts.

Grendell R.L., Magness R.R., Golos T.G.

Placenta 28:383-389(2007).

The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.

Hiraga H., Nojima T., Nagashima K., Schaefer K.-L., Lee K.A.W.

Br. J. Cancer 89:1072-1078(2003).

Human choriocarcinoma cell line JEG-3 produces and secretes active retinoids from retinol.

Sapin V.

Mol. Hum. Reprod. 8:485-493(2002).

Adhesion and invasion of three human choriocarcinoma cell lines into human endometrium in a three-dimensional organ culture system.

Grummer R., Hohn H.-P., Mareel M.M., Denker H.-W.

Placenta 15:411-429(1994).

Analysis of the p53 gene in human choriocarcinoma cell lines.";

Yaginuma Y., Yamashita T., Takuma N., Katayama H., Ishikawa M.

Br. J. Cancer 71:9-12(1995).

Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene.

Brown A.D., Lopez-Terrada D.H., Denny C.T., Lee K.A.W.

Oncogene 10:1749-1756(1995).

Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins.

Rousset M., Zweibaum A., Fogh J.

Cancer Res. 41:1165-1170(1981).

Polymorphic enzyme analysis of cultured human tumor cell lines.";

Dracopoli N.C., Fogh J.

J. Natl. Cancer Inst. 70:469-476(1983).

Isolation of hormone-producing clonal lines of human choriocarcinoma.

Kohler P.O., Bridson W.E.

J. Clin. Endocrinol. Metab. 32:683-687(1971).

Human tumor lines for cancer research.";

Fogh J.

Cancer Invest. 4:157-184(1986).

Expression of HLA class I and class II antigens in human choriocarcinoma cell lines.

Yamashita K., Nakamura T., Shimizu T., Katagiri M., Ikeda H.

Int. J. Gynaecol. Obstet. 24:301-307(1986).

Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Fogh J., Wright W.C., Loveless J.D.

J. Natl. Cancer Inst. 58:209-214(1977).

One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.

Fogh J., Fogh J.M., Orfeo T.

J. Natl. Cancer Inst. 59:221-226(1977).

Ectopic and eutopic secretion of chorionic gonadotropin and its subunits in vitro: comparison of clonal strains from carcinomas of lung and placenta.

Rosen S.W.

J. Natl. Cancer Inst. 56:911-917(1976).

Choriocarcinoma.";

Ganapathy V., Prasad P.D., Leibach F.H.

(In book chapter) Human cell culture. Vol. 2. Cancer cell lines part 2; Masters J.R.W., Palsson B.O. (eds.); pp.141-147; Kluwer Academic Publishers; New York; USA (1999).

Web Resources